SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-030448
Filing Date
2021-05-27
Accepted
2021-05-27 16:21:00
Documents
13
Period of Report
2021-05-27
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bmea-8k_20210527.htm   iXBRL 8-K 44217
2 EX-99.1 bmea-ex991_15.htm EX-99.1 130258
  Complete submission text file 0001564590-21-030448.txt   314533

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bmea-20210527.xsd EX-101.SCH 5792
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bmea-20210527_lab.xml EX-101.LAB 19449
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bmea-20210527_pre.xml EX-101.PRE 11639
6 EXTRACTED XBRL INSTANCE DOCUMENT bmea-8k_20210527_htm.xml XML 3536
Mailing Address 726 MAIN STREET REDWOOD CITY CA 94063
Business Address 726 MAIN STREET REDWOOD CITY CA 94063 (650) 980-9099
Biomea Fusion, Inc. (Filer) CIK: 0001840439 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40335 | Film No.: 21972998
SIC: 2834 Pharmaceutical Preparations